[PDF] Top 20  FIXED DOSE COMBINATION AND DISEASE MANAGEMENT

... of combination product/ fixed dose combinations ...(FDCs). Combination products, also known as fixed dose drug combinations (FDCs) drug, are combinations of two or more active ... See full document

... 2–4) who participated in 26 studies, among which 17 placebo-controlled trials and 9 trials in which TIO/OLO was compared with TIO. A total of 9855 patients were in the OLO arm and 6736 were in the control arm. In the ... See full document

... characteristics, including sex distribution (55% men), age (mean = 53 years old), proportion that were $65 years old (14%), diabetes (10%), and ethnicity (17% black and 26% Hispanic) were similar across all treatment ... See full document

... Hypertension is a very common and serious condition which can lead to many health related problems and cardiovascular disease (CVD). It is the most important cause of morbidity and mortality. It is estimated that ... See full document

... ACKNOWLEDGEMENT: The authors are thankful to Lupin Pharmaceuticals, J & K, India, for providing standard drug samples. The authors are grateful to the Principal and the Management of STES’s Smt. Kashibai ... See full document

... Overall, the evidence suggests that combination therapy with memantine and donepezil does provide significant advantages across multiple domains compared with ChEI monotherapy. Patients who may particularly ... See full document

... risk management, where multiple risk factors are modified simul- taneously, is a more effective way of reducing ASCVD events than focusing on single risk factors in isolation (Gaede ... See full document

... xed dose combination containing the AT 1 -receptor blocker valsartan (160 mg) and the dihy- dropyridine amlodipine (5 or 10 ...xed-dose combination based on amlodipine and valsartan is ... See full document

... data from classical RCTs should be completed with effective- ness data obtained in real-life studies (ie, pragmatic trials and observational studies), which may yield more realistic data in this regard. Importantly, ... See full document

... The present study has the inherent limitations of noninter- ventional studies, including lack of a control group and no randomization. Therefore, the BP lowering reported may be a higher estimate than the true effect. On ... See full document

... from fixed-dose combina- tion therapy with sitagliptin/metformin include those patients with hyperglycemia who are uncontrolled on metformin or sitagliptin alone, those who tend toward hypoglycemia when ... See full document

... India Fixed Dose Combination (FDC) of Drugs / medicines has drawn the attention of health service providers and the service ...A fixed dose combination (FDC) is a formulation of ... See full document

... PRECAUTIONS UPRIGHT may cause dizziness. Driving or operating machinery are to be avoided. Individuals receiving long-term treatment should be regularly monitored for renal function tests, liver function tests and blood ... See full document

... investigator classified half the patients as having symptoms 1e2 times per week, suggesting that the patients them- selves over-estimated their own asthma control. Low ACT scores are thought to indicate uncontrolled ... See full document

... other disease process such as family history can develop hypertension with individual who is suffering from diabetes, obesity or disability status all are more likely to have hypertension than ... See full document

... amlodipine with separate-pill HCT also indicated that age did not have a relevant influence on the ADR rate. Drug- related hypotension and orthostatic hypotension, however, occurred less frequently in patients aged ... See full document

... arms respectively. The most common unrelated AEs encountered during the study were the manifestations of the disease: fever, body pain, fatigue and asthenia during the hospitalized observation period. The more ... See full document

... the disease. Several combination formulation compounds of long-acting muscarinic antagonists (LAMAs) and long-acting β 2 agonists (LABAs) have been clinically tested or are in the process of formulation, ... See full document

... The present study revealed a significant reduction in the frequency of GI ulcers in high-risk patients with arthritis. Several strategies and guidelines for NSAIDs have been proposed for patients taking NSAIDs who are at ... See full document

... Figure 2 Mean reductions from baseline in SBP and DBP following initial fi xed-dose irbesartan/hydrochlorothiazide (HCTZ) 300/25 mg treatment, according to age, body mass index (BMI), type 2 diabetes, and ... See full document